You have 9 free searches left this month | for more free features.

Condition

Glaucoma and Ocular Hypertension (1)

Healthy Male Adults (1)

Open Angle Glaucoma or Ocular Hypertension (1)

Overall Status

Completed (3)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

phase 3 (1)

Sponsor

Santen Pharmaceutical Co., Ltd. (2)

Santen Inc. (1)

Collaborator

Intervention

de-117 (3)

0.0015% tafluprost (1)

de-117 and 0.0015% tafluprost (1)

latanoprost ophthalmic solution (1)

placebo (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

de-117

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Open Angle Glaucoma or Ocular Hypertension Trial in Singapore (DE-117, Latanoprost ophthalmic solution)

Completed

Open Angle Glaucoma or Ocular Hypertension

DE-117
Latanoprost ophthalmic solution

Singapore, Singapore

(unnamed)

Jun 9, 2019

Glaucoma and Ocular Hypertension Trial in United States (DE-117, 0.0015% tafluprost, DE-117 and 0.0015% tafluprost)

Completed

Glaucoma and Ocular Hypertension

DE-117
+3 more

Newport Beach, California
+9 more

Apr 16, 2018

Healthy Male Adults Trial in Kagoshima (DE-117)

Completed

Healthy Male Adults

DE-117

Kagoshima, Japan

CPC Clinical Trial Hospital, Medipolis Medical Research Institut

Jun 28, 2016